The global clinical trial packaging market size accounted for USD 3.30 billion in 2024, grew to USD 3.65 billion in 2025 and is predicted to surpass around USD 9.12 billion by 2034, representing a healthy CAGR of 10.70% between 2024 and 2034. The North America clinical trial packaging market size is calculated at USD 1.68 billion in 2024 and is expected to grow at a fastest CAGR of 10.81% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Clinical Trial Packaging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Clinical Trial Packaging Market, by Clinical Trial Type, 2024-2034
8.1.1. Therapeutic and Prevention
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Diagnostics
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Clinical Trial Packaging Market, by Packaging Type e, 2024-2034
9.1.1. Syringes
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Vials & Ampoules
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Blisters
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Tubes
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Bottles
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Bags & Pouches
9.1.6.1. Market Revenue and Forecast (2021-2034)
9.1.7. Sachets
9.1.7.1. Market Revenue and Forecast (2021-2034)
9.1.8. Kits or Packs
9.1.8.1. Market Revenue and Forecast (2021-2034)
9.1.9. Others
9.1.9.1. Market Revenue and Forecast (2021-2034)
10.1. Clinical Trial Packaging Market, by Material, 2024-2034
10.1.1. Plastic
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Glass
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Metal
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Paper
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Corrugated Fiber
10.1.5.1. Market Revenue and Forecast (2021-2034)
11.1. Clinical Trial Packaging Market, by End User, 2024-2034
11.1.1. Research Laboratories
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Clinical Research Organizations
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Drug Manufacturing Facilities
11.1.3.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.1.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.1.3. Market Revenue and Forecast, by Material (2021-2034)
12.1.4. Market Revenue and Forecast, by End User (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Material (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Material (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.2.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.2.3. Market Revenue and Forecast, by Material (2021-2034)
12.2.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Material (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Material (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Material (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Material (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.3.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.3.3. Market Revenue and Forecast, by Material (2021-2034)
12.3.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Material (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Material (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Material (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Material (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.4.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.4.3. Market Revenue and Forecast, by Material (2021-2034)
12.4.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Material (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Material (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Material (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Material (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.5.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.5.3. Market Revenue and Forecast, by Material (2021-2034)
12.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Material (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Clinical Trial Type (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Packaging Type (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Material (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End User (2021-2034)
13.1. Bilcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Fisher Clinical Services
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. WuXi AppTec
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. PCI Pharma Services
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Almac Group
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. PharMaterials
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. PAREXEL
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Schreiner MediPharm
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Sharp Packaging
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. The Coghlan Group
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample